Skip to content
Relmada Therapeutics
$115,000,000
Common Stock
December 2019
Read More
General Cannabis Corp.
$3,000,000
Private Placement of Common Stock
Represented FINRA Member Firm
June 2019
Read More
INmune Bio Inc.
$8,000,000
Initial Public Offering
January 2019
Read More
Pareteum Corporation
$40,000,000
Common Stock and Warrants
September 2019
Read More
Pareteum Corporation
$6,100,000
Registered Direct Offering
Common Stock
May 2018
Read More
Acolyte Group
Sale to Private Equity Firm
May 2018
Read More
QBIO Med, Inc.
$5,500,000
Common Stock and Warrants
Represented Roth Capital Partners as lead Placement Agent
January 2018
Read More
Vuzix Corporation
$30,000,000
Registered Direct Offering
Common Stock and Warrants
January 2018
Read More
Pareteum Corporation
$12,000,000
Common and Preferred Stock
November 2017
Read More
Ampio Pharmaceuticals, Inc.
$6,750,000
Registered Direct Public Offering of Common Stock
Represented Joseph Gunnar & Co. as Lead Placement
October 2017
Read More
